Kailera Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- January 04, 2025
- Vertical
- Biopharmaceuticals
- Funding URL
- View Funding Page
- Funding Amount:
- $400,000,000
Company Info
- Company Description
- Kailera Therapeutics is a clinical-stage biopharmaceutical company focused on advancing a broad pipeline of next-generation therapies for the treatment of obesity and related conditions.
- Market
- Obesity and related conditions
- Location
- Boston, MA, USA
- Coinvestors
- Atlas Venture, Bain Capital Life Sciences, RTW Investments, Lyra Capital